Daily aspirin does not reliably prevent bowel cancer in people at average risk, according to a major new review. Any ...

Doctors have long recommended daily aspirin for years as a low-cost protection against cancers of the lower bowel. New research suggests there might not be a dependable benefit for low-risk patients.

Add Yahoo as a preferred source to see more of our stories on Google. The debate over whether people ages 60 and up should take aspirin continues as medical experts learn more about the potential pros ...

New evidence shows regular aspirin use is associated with a lower incidence of aortic valve calcification and aortic stenosis ...

Health experts warn that frequent use of ibuprofen, aspirin and naproxen may increase the risk of serious health problems, including kidney and heart complications.

People at risk of colorectal cancer are sometimes prescribed daily aspirin. Scientists look into that preventative ...

Some believe that aspirin and similar drugs can provide simple protection against bowel cancer. A large study from China now shows that this hope is unlikely to be fulfilled.

Older adults without heart disease shouldn't take daily low-dose aspirin to prevent a first heart attack or stroke, an influential health guidelines group said in preliminary updated advice released ...

Taking low-dose aspirin every day may lower the overall risk of cancer by 3 percent, mostly because of larger reductions that were seen in the risk for colon and gastrointestinal tumors, researchers ...

For years, taking a daily aspirin was believed to be one of the easiest ways to protect long-term health. But the bottom line on aspirin has recently gotten more complicated. Some research finds that ...

Aspirin is a bit of an overachiever. Besides easing your headaches, the magical over-the-counter med can enhance your health, appearance, and even your hair. Here are five surprising uses for the ...

In patients with diabetes and multivessel CAD, ticagrelor fails to meet noninferiority criteria compared with prasugrel at 1-year post-PCI.